Philip Rackliffe's most recent trade in GE HealthCare Technologies Inc was a trade of 14,058 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GE HealthCare Technologies... | Philip Rackliffe | CEO, AVS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 14,058 | 14,058 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Technologies... | Philip Rackliffe | CEO, AVS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 4,916 | 17,473 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Technologies... | Philip Rackliffe | CEO, AVS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.30 per share. | 01 Feb 2025 | 158 | 12,557 | - | 88.3 | 13,951 | Common Stock, par value $0.01 per share |
| GE HealthCare Technologies... | Philip Rackliffe | CEO, AVS | 05 Nov 2024 | 900 | 12,715 | - | 87.6 | 78,867 | Common Stock, par value $0.01 per share | |
| GE HealthCare Technologies... | Philip Rackliffe | CEO, Ultrasound & IGT | 01 Sep 2024 | 1,388 | 13,780 | - | 84.8 | 117,730 | Common Stock, par value $0.01 per share | |
| GE HealthCare Technologies... | Philip Rackliffe | CEO, Ultrasound & IGT | 01 Sep 2024 | 165 | 13,615 | - | 84.8 | 13,995 | Common Stock, par value $0.01 per share | |
| GE HealthCare Technologies... | Philip Rackliffe | CEO, Ultrasound & IGT | 15 Aug 2024 | 6,203 | 6,203 | - | - | Employee Stock Option (right to buy) | ||
| GE HealthCare Technologies... | Philip Rackliffe | CEO, Ultrasound & IGT | 15 Aug 2024 | 2,051 | 15,168 | - | 0 | Common Stock, par value $0.01 per share |